DÄ internationalArchiveReferences
References

Review article

The Undescended Testis

Dtsch Arztebl Int 2009; 106(33): 527-32. DOI: 10.3238/arztebl.2009.0527

Mathers, M J; Sperling, H; Rübben, H; Roth, S

1. Virtanen HE, Cortes D, Raipert-De Mayts E, Ritzen M, Nordenskjoid A, Skakkebaek NE Toppari J: Development and descent of the testis in relation to cryptorchidism. Acta Paediatr 2007; 96: 622–7. MEDLINE
2. Leitlinie der Deutschen Gesellschaft für Kinderchirurgie, der Deutschen Gesellschaft für Urologie und der Deutschen Gesellschaft für Kinder- und Jugendmedizin, vertreten durch die Arbeitsgemeinschaft für pädiatrische Endokrinologie (APE) (2008): Hodenhochstand – Maldeszensus testis. www.uni-duesseldorf.de/AWMF/ll/006–022.htm.
3. Zöller G, Ringert, Hermann R: Hodenhochstand im Kindesalter – oft zu spät behandelt. Dtsch Arztebl 2005; 102(24): A 1750–2. VOLLTEXT
4. Pettersson A, Richiardi L, Nordenskjoid A, Kaijser M, Akre O: Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 2007; 356(18): 1835–41. MEDLINE
5. Docimo, S, Silver RI, Crome W: The undescended testicle: diagnosis and treatment. Am Fam Physician 2000; 62(9): 2037–44, 2047–8. MEDLINE
6. Toppari J, Kaleva M: Maldescensus testis. Horm Res 1999; 51: 261–9. MEDLINE
7. Berkowitz GS, Lapinski RH, Dolgin SE, Gazella JG, Bodian CA, Holzman IR: Prevalence and natural history of cryptorchidism. Pediatrics 1993; 92: 44–9. MEDLINE
8. Thorup J, Cortes D, Petersen BL: The incidence of bilateral cryptorchidism is increased and the fertility potential is reduced in sons born to mothers who have smoked during pregnancy. J Urol 2006; 176: 734–7. MEDLINE
9. Roth S, Ubrig B, Semjonow A, Rathert P: Klinische Urologie. Berlin, Heidelberg: Springer Verlag 2001: 67–9.
10. Rajfer J, Handelsman DJ, Swertloff RS, et al.: Hormonal therapy of cryptorchidism. N Engl J Med 1986; 314: 466. MEDLINE
11. Hadziselimovic F: Cryptorchidism, its impact on male fertility. Eur Urol 2002; 41: 121–3. MEDLINE
12. Hadziselimovic F, Herzog B: The importance of both an early orchidopexy and germ cell maturation for fertility. Lancet 2001; 358: 1156–7. MEDLINE
13. Cisek LJ, Peters CA, Atala A et al.: Current findings in diagnostic laparoscopic evaluation of the nonpalpable testis. J Urol 1998;160: 1145–50. MEDLINE
14. Docimo SG: The results of surgical therapy for cryptorchidism: a literature review and analysis. J Urol 1995; 154: 1148–52. MEDLINE
15. Baker LA, Docimo SG, Surer I, et al.: A multi-institutional analysis of laparoscopic orchidopexy. BJU Int 2001; 87: 484–9. MEDLINE
16. Esposito C, Garipoli V: The value of 2-step laparoscopic Fowler-Stephens orchidopexy for intra-abdominal testes. J Urol 1997; 158: 1952–4. MEDLINE
17. Melchior D, Kaefer M, Eugster E, Havlik R: A novel microvascular approach to treatment of the high undescended testicle. J Pediatr Surg 2002; 37: 1501–3. MEDLINE
18. Fowler R, Stephens FD: The role of testicular vascular anatomy in the salvage of high undescended testes. Aust NZ J Surg 1959; 29: 92–106. MEDLINE
19. Strittmatter T: Testicular Autotransplantation – The Mönchengladbach Experience. Horm Res 2001; 55: 52. MEDLINE
20. Miller KD, Coughlin MT, Lee PA: Fertility after unilateral cryptorchidism. Paternity, time to conception, pre-treatment testicular localization and size, hormone and sperm parameter. Horm Res 2001; 55: 249–53. MEDLINE
21. Virtanen HE, Bjerknes R, Cortes D, Jørgensen N, Rajpert-De Meyts E, Thorsson AV, Thorup J, Main KM: Cryptorchidism: classification, prevalence and long-term consequences. Acta Paediatr 2007; 96(5): 611–6. MEDLINE
22. Friedman RM, Lopez FJ, Tucker JA, King LR, Negro-Vilar A: Fertility after cryptorchidism: a comparative analysis of early orchiopexy with and without concomitant hormonal therapy in the young male rat. J Urol 1994; 151: 227–33. MEDLINE
23. Dieckmann KP, Pichlmeier U: Clinical epidemiology of testicular germ cell tumors. World J Urol. 2004; 22: 2–14. MEDLINE
24. Ekbom A: Growing evidence that several human cancers may originate in utero. Semin Cancer Biol 1998; 8: 237–44. MEDLINE
25. Rajpert-De Mayts E: Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 2006; 12(3): 303–23. MEDLINE
e1. Bergh A, Soder O: Studies on cryptorchidism in experimental animal models. Acta Paediatr 2007; 96: 617–21. MEDLINE
e2. Chilvers c, Dudley NE, Gough MH et al.: Undescended testis: The effect of treatment on subsequent risk of subfertiltiy and malignancy. J Pediatr Surg 1986; 21: 691–6. MEDLINE
e3. Swerdlow AJ, Higgins CD, Pike MC: Risk of testicular cancer in cohort of boys with cryptorchidism. BMJ 1997; 315: 1129. MEDLINE
e4. Akre O, Lipworth L, Cnattingius S, Sparen P, Ekbom A: Risk factor patterns for cryptorchidism and hypospadias. Epidemiol 1999; 10: 364–9. MEDLINE
e5. McGlynn KA, Graubard BI, Nam JM, Stanczyk FZ, Longnecker MP, Klebanoff MA: Maternal hormone levels and risk of cryptorchidism among populations at high and low risk of testicular germ cell tumors. Epidemiol Biomarkers Prev 2005; 14: 1732–7. MEDLINE
e6. Swan SH, Main KM, Liu F, Steqart SL, Kruse RI, Calafat AM et al.: Study for Future Famililies Research Team: Anogenital distance—a marker of fetal androgen action—is decreased in male infants following phthalate exposure during pregnancy. Environ Health Perspect 2005; 113: 1056–61.
e7. Main KM, Mortensen GK, Kaleva MM, Boisen KA, Damgaard IN, Chelladooty M et al.: Human breast milk contamination with phthalates and alterations in endogenous reproductive hormones in infants three months of age. Environ Health Persoect 2006; 114: 270–6. MEDLINE
e8. Elder JS: Cryptorchidism: isolated and associated with other genitourinary defects. Pediatr Clin North Am 1987; 34: 1033–53. MEDLINE
e9. Kanemoto K, Hayashi Y, Kojima Y, Maruyama T, Ito M, Kohri K: Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of non-palpable testis. Int J Urol 2005; 12: 668–72.
e10. Lee MM, Donahoe PK, Silverman BL, Hasegawa T, Hasegawa Y, Gustafson ML et al.: Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads. N Engl J Med 1997; 336: 1480. MEDLINE
e11. Koop CE: Technique of herniorraphy and orchidopexy. Birth Defects Orig Artic Ser 1977; 13: 293–303. MEDLINE
e12. Albers N: Konservative Therapie des Hodenhochstandes. Monatsschrift Kinderheilkd 2005; 153: 436–43.
e13. Dickerman Z, Bauman B, Sandovsky U et al.: HCG treatment in cyptorchidism. Andrologia 1983; 16: 542.
e14. Lala R, Matarazzo P, Chiabotto P et al.: Combined therapy with LHRH and HCG in cyptorchid infants. Eur J Pediatr 1993; 152: 31. MEDLINE
e15. Schwentner C, Oswald J, Kreczy A, Lunacek A, Bartsch G, Deibl M, Radmayr C.: Neoadjuvant gonadotropin-releasing hormone therapy before surgery may improve the fertility index in undescended testes: a prospective randomized trial. J Urol. 2005; 173(3): 974–7. MEDLINE
e16. Pyörälä S, Huttumen NP, Uhari M: A review and meta-analysis of hormonal treatment of cryptorchidism. J Clin Endocrinol Metab 1995; 80: 2795–9. MEDLINE
e17. Ritzen EM, Bergh A, Bjerknes R, Christiansen P, Cortes D et al.: Nordic consensus on treatment of undescended testes. Acta Paediatr. 2007; 96(5): 638–43. MEDLINE
e18. Christiansen P, Müller J, Buhl S, Hansen OR, Hobolth N, Jacobsen BB, Jørgensen PH, Kastrup KW, Nielsen K, Nielsen LB et al.: Hormonal treatment of crytorchidism—hCG or GnRH—a multicentre study. Acta Paediatr 1992; 81(8): 605–8. MEDLINE
e19. Rose A, Sperling H, Steffens J et al.: Multimodale Therapie des Maldeszensus testis. Urologe 2006 [Sonderheft] 45: 214–8.
e20. Schleef J, v. Bismarck S, Burmucic K, Gutmann A, Mayr J: Groin exploration for nonpalpable testes: laparoscopic approach. J Pediatr Surg 2002; 11: 1552–5. MEDLINE
e21. Williams EV, Appanna T, Foster ME: Management of the impalpable testis: a six year review together with a national experience. Postgrad Med J 2001; 77: 320–2. MEDLINE
e22. Chang B, Palmer LS, Franco I: Laparoscopic orchidopexy: a review of a large clinical series. BJU Int 2001; 87: 490–3. MEDLINE
e23. Lindgren BW, Franco I, Blick S et al.: Laparoscopic Fowler-Stephens orchidopexy for the high abdominal testis. J Urol 1999; 162: 990–4. MEDLINE
e24. Kogan SJ: Fertility in cryptorchidism. An overview in 1987. Eur J Pediatr 1987;146(suppl 2): S21–4. MEDLINE
e25. McAleer IM, Packer MG, Kaplan GW, Scherz HC, Krous HF, Billman GF: Fertility index analysis in cryptorchidism. J Urol 1995; 153: 1255–8. MEDLINE
e26. Pinczowski D, McLaughlin JK, Lackgren G, Adami HO, Persson I: Occurrence of testicular cancer in patients operated on for cryptorchidism and inguinal hernia. J Urol 1991; 146: 1291–4. MEDLINE
e27. Weir HK, Marrett LD, Kreiger N, Darlington GA, Sugar L: Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer 2000; 87: 438–43. MEDLINE
e28. Giwercman A, Bruun E, Frimodt-Møller C, Skakkebaek NE: Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol 1989; 142: 998–1001. MEDLINE
e29. Skakkebaek NE: Possible carcinoma-in-situ of the testis. Lancet 1972; 2: 516–7. MEDLINE
e30. Martin DC: Malignancy in the cryptorchid testis. Urol Clin North Am 1982; 9: 371–6.
e31. Herrington LJ, Zhao W, Husson G: Management of cryptorchidism and risk of testicular cancer. Am J Epidemiol 2003; 157: 602–5. MEDLINE